• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts

    Источник: Buzz FX / 05 окт 2024 01:06:12   America/Chicago


    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
    Read more...
Опубликовать